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Abstract
Background: An important physiological function of the normal prostate gland is the synthesis
and secretion of a citrate rich prostatic fluid. In prostate cancer, citrate production levels are
reduced as a result of altered cellular metabolism and bioenergetics. Na, K-ATPase is essential for
citrate production since the inward Na+ gradients it generates are utilized for the Na+ dependent
uptake of aspartate, a major substrate for citrate synthesis. The objective of this study was to
compare the expression of previously identified Na, K-ATPase isoforms in normal canine prostate,
benign prostatic hyperplasia (BPH) and prostatic adenocarcinoma (PCa) using
immunohistochemistry in order to determine whether reduced citrate levels in PCa are also
accompanied by changes in Na, K-ATPase expression.
Results:  Expression of Na, K-ATPase α1 and β1 isoforms was observed in the lateral and
basolateral plasma membrane domains of prostatic epithelial cells in normal and BPH prostates.
Canine kidney was used as positive control for expression of Na, K-ATPase α1 and γ isoforms. The
α1 isoform was detected in abundance in prostatic epithelial cells but there was no evidence of α2,
α3 or γ subunit expression. In advanced PCa, Na, K-ATPase α1 isoform expression was significantly
lower compared to normal and BPH glands. The abundant basolateral immunostaining observed in
normal and BPH tissue was significantly attenuated in PCa.
Conclusion: The loss of epithelial structure and function and the transformation of normal
epithelial cells to malignant cells in the canine prostate have important implications for cellular
metabolism and are accompanied by a down regulation of Na, K-ATPase.
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Background
The principal physiological function of the prostate gland
is the synthesis, accumulation and secretion of the anion
citrate [1]. Citrate may be used as an important energy
source for spermatozoa, or involved as a buffer or chelator
of cations in seminal fluid [2]. Na+ dependent uptake of
aspartate from plasma is achieved by two kinetically dis-
tinct Na+-dependent transport systems to create a high
cytosolic aspartate concentration [3]. Aspartate provides
the intra-mitochondrial source of oxaloacetate while glu-
cose provides the source of acetyl-CoA for citrate biosyn-
thesis [4]. Ouabain-sensitive Na, K-ATPase-mediated
transport is critical for aspartate uptake, citrate production
and prostatic fluid formation since the inward Na+ gradi-
ents generated by Na, K-ATPase are utilized for the Na+
dependent uptake of aspartate. Na+ and K+ also represent
a large component of prostatic fluid osmolarity [5] and
their levels are finely regulated by plasma membrane
transport systems that have yet to be identified. Further-
more, androgen activation of Na, K-ATPase serves as a
metabolic pacemaker in the prostate [6,7] exerting tran-
scriptional control over the expression of Na, K-ATPase
subunits, which play a critical role in the biogenesis of Na,
K-ATPase in prostate cancer [8,9]. In normal prostate, cit-
rate concentrations in prostatic fluid range from 40 to 150
mM. In prostate cancer however, citrate production levels
are significantly reduced as a result of altered cellular
metabolism and bioenergetics [4].
Na, K-ATPase is an important regulator of intracellular
electrolyte levels in almost all mammalian cells [10,11]. It
is a Mg2+-dependent P-type transport pump responsible
for maintaining the low intracellular Na+:K+ ratio that is
essential for cell homeostasis and physiological function.
It catalyzes the active uptake of K+ and extrusion of Na+ at
the expense of hydrolyzing ATP with a stoichiometry of
3Na+ for 2K+. The active form of Na, K-ATPase is an inte-
gral membrane protein complex primarily composed of
two non-covalently attached subunits; a 110-kDa catalytic
α subunit and a 45–55-kDa glycosylated β subunit. The α
subunit has binding sites for Na+, K+, ATP and cardiac gly-
cosides (digitalis and ouabain) [12]. Four α isoforms
encoded by different genes have been identified which are
~85% identical at the protein level [13,14]. The β subunit
is a complex type II glycoprotein with a short cytoplasmic
NH2 terminus, a single transmembrane domain and a
large globular COOH ectodomain containing three
disulfide bridges and sites for N-linked glycosylation.
Renal Na, K-ATPase consists of an additional small com-
ponent known as the γ subunit [15,16]. The γ subunit is a
member of the FXYD family of small ion transport regula-
tors [17] and is believed to be responsible for fine regula-
tion of Na+ transport in the nephron by modulating the
transport function of renal Na, K-ATPase [18,19].
We have previously shown that human and rat prostatic
epithelial cells express the α1, β1 and β2 isoforms of Na,
K-ATPase [20,11]. Despite the importance of Na, K-
ATPase function for citrate production there is no infor-
mation about its expression patterns in hyperplastic or
neoplastic prostate. The objective of this study was to
determine the localization of Na, K-ATPase and to com-
pare expression of Na, K-ATPase isoforms in normal
canine prostate, benign prostatic hyperplasia (BPH) and
prostatic adenocarcinoma (PCa) in order to determine
whether reduced citrate levels in PCa are also accompa-
nied by changes in Na, K-ATPase expression.
Results
In normal prostatic tissue (Fig. 1, panel A) glands are lined
with a relatively continuous sheet of simple cuboidal to
low columnar/pseudostratified epithelial cells which are
separated by stromal connective tissue consisting of
smooth muscle, blood vessels and neuroendocrine cells.
Normal glands exhibit large lumens without evidence of
tufting or micropapillae. The tissue in panel B exhibits all
the classic morphological features of BPH; the tubuloalve-
oli vary in size and form with many of the individual
Histological appearance of normal (A), BPH (B) and PCa  canine prostate tissues incorporated in this study Figure 1
Histological appearance of normal (A), BPH (B) and PCa 
canine prostate tissues incorporated in this study. In the nor-
mal prostate continuous sheets of epithelial cells (ec) are 
separated by connective tissue stroma (S) consisting of blood 
capillaries (indicated by closed arrows), smooth muscle and 
neuroendocrine cells. BPH glands display smaller lumens (L) 
compared to normal tissue with evidence of tufting and 
micropapillae. PCa glands are lined with neoplastic cells 
exhibiting cellular and nuclear pleomorphisms and numerous 
mitotic figures (open arrows). The basal cells (bc) were irreg-
ular in contour but the basement membrane appears conflu-
ent. Original magnifications: × 400.Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/8
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glands appearing cystically dilated or collapsed. Epithelia
consist of columnar cells but some basal cells are also
present. Panel C shows sheets of neoplastic epithelial cells
that are morphologically typical of high-grade adenocarci-
noma. Epithelial and stromal cells are densely packed and
disorganized. There is marked cellular and nuclear pleo-
morphism and numerous mitotic figures are observed
particularly in the epithelial cells layer. Enlarged hyper-
chromatic nuclei display marked anisokaryosis. Nucleoli
are large and prominently multiplied. The basal cell layer
is often irregular in contour but basement membranes
appear confluent. Micro-glands exhibit ill-defined lumens
significantly constricted by the geometric progression of
proliferating cells.
Expression of Na, K-ATPase α1 and β1 isoforms was
observed in the lateral and basolateral plasma membrane
domains of prostatic epithelial cells in normal and BPH
prostates (Fig. 2). In advanced PCa, Na, K-ATPase expres-
sion was significantly lower compared to normal and BPH
glands (Fig. 2). The expression observed in high grade
(poorly differentiated) adenocarcinomas was significantly
lower than low grade (well differentiated tumours); the
abundant basolateral immunostaining observed in nor-
mal and BPH tissue was significantly reduced in high
grade PCa as determined by immunohistochemistry using
a monoclonal pan α antibody (mAb9A7) that has been
shown to recognize the α1 isoform in addition to all other
known  α isoforms [21] (Fig. 3). Identical results were
obtained using the α5 monoclonal pan α antibody
(results not shown). Image analysis confirmed the down-
regulation of Na, K-ATPase (Fig. 5).
The α1 isoform was detected in abundance but there was
no evidence of α2 or α3 isoform expression (Fig. 4A). The
γ isoform was not detected in canine prostate (Fig. 4B).
Canine kidney was used as a positive control to confirm
that the polyclonal antibodies raised against the rodent γ
isoform recognize the canine γ isoform expressed in the
nephron (Fig. 4B). Although the γ isoform was not
detected in all nephron segments, it was found in low lev-
els in basolateral membranes of proximal convoluted
tubules and in very high levels in the medullary thick
ascending limbs, distal convoluted tubules and connect-
ing tubules. The γ isoform was not present in the medul-
lary and papillary collecting ducts.
Discussion
The results of this study reveal that the α1 and β1 subunits
are the dominant Na, K-ATPase isoforms expressed in the
basolateral membranes of epithelial cells in normal and
BPH canine prostate. The α2, α3 and γ subunits of Na, K-
ATPase are not expressed in this tissue. Immunohisto-
chemical and image analyses performed in this study sug-
gest that Na, K-ATPase expression is significantly reduced
in canine PCa. The cause of this down-regulation is not
known at present but it may be associated with the loss of
epithelial polarity and function in prostate cancer. It may
Immunohistochemical staining of Na, K-ATPase α1 and β1 subunits in canine normal, BPH and PCa tissues Figure 2
Immunohistochemical staining of Na, K-ATPase α1 and β1 subunits in canine normal, BPH and PCa tissues. Sites of Na, K-
ATPase immunoreactivity are stained red (using Fast-Red TR/Naphthol AS-MX as precipitating substrate for the alkaline phos-
phatase conjugated secondary antibody). In normal and BPH sections Na, K-ATPase immunostaining is clearly visible in the 
basolateral membrane domain of epithelial cells (arrows). In three different PCa specimens Na, K-ATPase expression levels 
appear to be significantly lower than in normal or BPH tissues and Na, K-ATPase is diffusely spread within focal areas of the 
neoplasm. Nuclei were counterstained with haematoxylin.Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/8
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also be related to the reduced citrate production and secre-
tion that accompanies neoplastic development in the
prostate [4]. There is, however, an argument against the
latter scenario: unlike the human prostate, the canine
counterpart does not produce huge quantities of citrate
(L.C. Costello, personal communication). Therefore, the
down-regulation of Na, K-ATPase could be intricately
involved in a series of other metabolic changes that occur
during the progression of prostate malignancy, or it could
merely be a consequence of such changes, which has little
effect in the process of neoplastic transformation.
Androgen ablation therapy is often used to treat advanced
prostate cancer – a treatment that is successful until the
malignant growth evolves resistance to this and becomes
androgen-independent [22]. Previous studies have indi-
cated that the β-subunit of Na, K-ATPase is down-regu-
lated in the prolonged presence of a synthetic androgen at
a transcriptional level, resulting in a reduction of func-
tional Na+, K+-ATPase in androgen-dependant prostate
cell-lines [9]. Studies have also shown that voltage acti-
vated sodium channel (VASC) activity and expression is
altered in prostate cancer cell lines [23] and VASC protein
expression has been shown to enhance the invasive, met-
astatic properties of rat and human prostate cancer cells
[24]. Taken together, these results suggest that neoplastic
development in the prostate is accompanied by changes
in cell homeostasis and expression levels of ion transport-
ers including Na, K-ATPase and VASC. Whether Na, K-
Comparing the immunohistochemical localization of Na, K-ATPase "α " subunits in normal, BPH and PCa tissues using a pan α  monoclonal antibody (mAb9A7) that recognizes all known α isoforms Figure 3
Comparing the immunohistochemical localization of Na, K-ATPase "α" subunits in normal, BPH and PCa tissues using a pan α 
monoclonal antibody (mAb9A7) that recognizes all known α isoforms. The pan α monoclonal antibody produces a staining pat-
tern which is identical to the α1 specific antibodies providing further evidence for the predominance of α1 expression in the 
prostate and the downregulation of Na, K-ATPase in PCa.Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/8
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ATPase expression is also reduced in human PCa remains
to be determined.
The metabolic transformation of zinc-accumulating cit-
rate-producing normal prostate epithelial cells to citrate-
oxidizing malignant neoplastic epithelial cells has impor-
tant implications for cell metabolism and appears to be
accompanied by a down regulation of Na, K-ATPase.
Given the importance of the altered intermediary metab-
olism of prostatic cells in the pathogenesis of malignant
prostatic adenocarcinoma and the progression of malig-
nancy [4,25], the focus of future studies will be to address
the role of Na, K-ATPase and other ion and metabolite
transporters as potential epigenetic factors which may
contribute to the metabolic transformation of sane cells to
neoplastic cells. Sodium and potassium flux pathways
(including Na, K-ATPase, Na/K/2Cl co-transport and volt-
age-gated Na+ channels) have already been studied in
prostate cancer cells lines in terms of their potential value
as targets for cytotoxic anti-neoplastic therapy [26–28].
Our results suggest that down-regulation of Na, K-ATPase
in prostate cancer may accompany the up-regulation of
voltage-gated sodium channels that has been observed by
other investigators, contributing to the hyper-excitability
of prostate cancer cells. These phenotypic changes will
influence citrate biosynthesis, zinc uptake and energy
metabolism (Fig. 6) and may promote neoplastic devel-
opment, galvanotaxis and metastasis [29]. Collectively
Panel A: Absence of Na, K-ATPase α2, α3 and γ isoform expression and comparison with α1 expression in canine prostate Figure 4
Panel A: Absence of Na, K-ATPase α2, α3 and γ isoform expression and comparison with α1 expression in canine prostate. 
Original magnifications: × 800. Panel B: Evidence to confirm that the γ C33 polyclonal raised against the rodent γ isoform rec-
ognizes the canine γ isoform protein in the canine kidney. The expression of the γ isoform is not detected in all nephron seg-
ments (i.e. medullary and papillary collecting ducts) but it is present in low levels in proximal convoluted tubules and in high 
levels in the medullary thick ascending limbs, and the distal nephron.Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/8
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Quantitative analysis of Na, K-ATPase immunoreactivity in normal, BPH and PCa canine prostate Figure 5
Quantitative analysis of Na, K-ATPase immunoreactivity in normal, BPH and PCa canine prostate. Panel A; results of image 
analysis experiments performed in triplicate comparing Na, K-ATPase expression levels in tissue sections immunoassayed with 
a polyclonal antibody to the α1 subunit of Na, K-ATPase under identical experimental conditions. Panels B and C; representa-
tive sections used for analysis. Panels D and E; plot profiles of Na, K-ATPase abundance in the BPH and PCa sections.Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/8
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Proposed scheme for the role of Na, K-ATPase in maintaining prostatic epithelial cell polarity and citrate-related energy  metabolism (adapted from a concept first proposed by Costello and Franklin, 2000[4]) Figure 6
Proposed scheme for the role of Na, K-ATPase in maintaining prostatic epithelial cell polarity and citrate-related energy 
metabolism (adapted from a concept first proposed by Costello and Franklin, 2000[4]). Normal prostate cells abundantly 
express basolateral Na, K-ATPase to maintain cell homeostasis and epithelial polarity. These cells contain specific transport 
mechanism for the accumulation of high levels of zinc and aspartate for optimal citrate biosynthesis. Aspartate, is transported 
into prostate epithelial cells on a high-affinity Na+-dependent carrier which resides in the basal cell membrane and is dependant 
on Na, K-ATPase activity [3]. The citrate transporter itself has yet to be identified but has been proposed to be localized in the 
apical membrane where it contributes to the accumulation of a citrate rich prostatic fluid [2,1]. The genetic transformation of 
a normal prostate cell to a neoplastic cell has been proposed to be accompanied by an impaired ability to accumulate high lev-
els of citrate. The neoplastic cell begins a metabolic transformation to a citrate-oxidizing cell, losing the ability to accumulate 
important factors such as zinc. Thus begins a metabolic conversion to a pre-malignant or malignant citrate-oxidizing cell. The 
loss of basolateral Na, K-ATPase appears to be one of a number of phenotypic changes that accompany this transformation. 
This alteration will no doubt influence the membrane potential, homeostatic responses to ionic perturbations mediated by ion 
channels and secretory functions.Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/8
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these observations have important implications for cellu-
lar homeostasis, bioenergetics and metabolism and justify
further functional (i.e. Na+ and K+ flux measurements)
and molecular studies to evaluate the role of ion transport
pathways and the regulation of their expression during
neoplastic development and metastasis in the prostate.
Methods
Tissues
Normal (2 prostates), BPH (2 prostates) and PCa (3 pros-
tates) were dissected from the cadaver of canines follow-
ing euthanasia. Normal and BPH tissue was obtained
from animals euthanased for non-related clinical reasons.
Canine kidneys were used as positive controls for expres-
sion of Na, K-ATPase γ subunit. All the procedures were
carried out in accordance with current local guidelines.
Tissues were fixed for 48 hrs in neutral buffered formalin
before being embedded in paraffin wax. The sections of
prostate tissue were histologically and morphologically
analyzed using established histpathological criteria (i.e.
cellular and nuclear pleomorphisms as evidence of
dysplastic and neoplastic alterations [30]) by two inde-
pendent veterinary pathologists and were categorized into
normal, BPH, well differentiated (low grade) and poorly
differentiated (high grade) adenocarcinomas.
Chemicals
All chemicals and secondary antibodies used were pur-
chased from Sigma Biosciences (Poole, Dorset, UK). Fast-
Red alkaline phosphatase precipitating agent was pur-
chased from Sigma/Aldrich (Poole, Dorset, UK).
Immunohistochemistry
Immunohistochemical studies were carried out on 8µm
paraffin sections mounted on 3-aminopropyl-triethoxysi-
lane (APES) treated slides. Normal, BPH and PCa tissues
were incubated for identical periods of time with antibod-
ies and the precipitating agent throughout the studies.
Sections were dewaxed in 100% xylene for 5 minutes and
taken through a graded series (100%, 70 % and 50%) of
alcohol baths for 1 min each before antigen retrieval in
the microwave oven in the presence of 10 mM citrate
buffer (pH 6.0) for 12 minutes. The sections were allowed
to cool before washing in phosphate buffered saline solu-
tion (PBS). Endogenous alkaline phosphatase was
blocked for one hour at room temperature (RT) by treat-
ment with 1.25 mM Levamisole solution (Vector Labora-
tories, Peterborough, UK). Non-specific protein binding
sites were blocked by addition of 10% normal goat serum
in PBS (1 hour RT). A panel of monoclonal and polyclo-
nal antibodies to the α and β subunits of Na, K-ATPase
was used (Table 1). Sections were incubated with primary
antibodies (various dilutions in PBS) for 24 hrs at 4°C
and subsequently washed in PBS before a two-hour incu-
bation with goat anti-rabbit IgG or goat anti-mouse IgG
conjugated to alkaline phosphatase. Tissue sections were
washed in PBS and alkaline phosphatase active sites were
developed using Fast-Red TR/Naphthol AS-MX as precipi-
tating agent for 10–15 minutes. Sections were counter-
stained with haematoxylin for 1 min and washed in
distilled water before mounting in aqueous medium and
visualization under a light microscope. Photographs were
taken using a Nikon Microphot-FX microscope fitted with
a Nikon DXM1200 digital camera or goat anti-mouse IgG.
Table 1: Isoform specific antibodies used to detect the isoforms of Na, K-ATPase in canine prostatic tissue by immunohistochemical 
analysis.
Antibody Isoform Specificity Working Dilution Source References
α5§ Recognizes all Neat Supernatant D. M. Fambrough [32]
Pan α (monoclonal) known α isoforms
mAb9A7 Recognizes all 1:100 M. Takahashi [21]
Pan α (monoclonal) known α isoforms
α620 (polyclonal) α1 specific 1:200 M.J. Caplan [33]
McB2 (monoclonal) α2 specific Neat Supernatant K.J. Sweadner [34]
XVIF9G10 (monoclonal) α3 specific Neat Supernatant K.P. Campbell [35]
SpETb1 (polyclonal) β1 specific 1:200 P. Martín-Vasallo [36]
SpETb2 (polyclonal) β2 specific 1:200 P. Martín-Vasallo [36]
γC33 (polyclonal) γ specific 1:200 S.J.D. Karlish [19]
§ The α5 monoclonal broadly recognizes Na+, K+-ATPase α subunits of avian, mammalian and insect species. There are 4 known α isoforms and the 
designation " α5" does not indicate the existence of a fifth Na+, K+-ATPase α isoform. The α5 antibody developed by D. Fambrough was also 
obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, 
Department of Biological Sciences, Iowa City, IA 52242, U.S.A. The monoclonal antibody XVIF9G10 developed by K.P. Campbell http://www.physi 
ology.uiowa.edu/campbell/public/Antibodies.htm is commercially available from Affinity Bioreagents.Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/8
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Image Analysis
Image analysis was carried out using Scion Image for Win-
dows (version 4.0.2 http://www.scioncorp.com/) based
on NIH Image for Macintosh. Sections used for image
analysis were only exposed to the Fast-Red precipitating
agent and not counterstained with hematoxylin.
Statistical analysis
The results are expressed as the means +/-SD of a repre-
sentative experiment performed in triplicate. The means
were compared using student's t-test assuming equal vari-
ances. p < 0.05 was considered statistically significant.
Note added in proof
In a very recent study of Na, K-ATPase α and β subunit
expression in bladder tumours, human urothelial cancer
tissue microarrays have been successfully used to demon-
strate that the mean protein expression for both α and β
subunits of Na, K-ATPase is reduced in invasive bladder
tumours compared to benign and dysplastic tissue [31].
These recent findings partially confirm our results in
canine prostate cancer. The authors have suggested that
Na, K-ATPase α and β subunit expression levels may be
useful predictors of clinical outcomes.
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